John Henneman
Chairman bij ANIKA THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
John B.
Henneman is currently the Chairman at Anika Therapeutics, Inc., an Independent Director at Orthofix Medical, Inc., a Director at Alafair Biosciences, Inc., a Director at Aprea Therapeutics AB, and the Lead Independent Director at R1 RCM, Inc. He was previously the Interim Co-Chief Executive Officer & Secretary at Neuromedical Systems, Inc., an Independent Director at SeaSpine Holdings Corp., the Chief Financial Officer at Integra LifeSciences Holdings Corp., the Chief Administrative Officer at NewLink Genetics Corp., and the President at New Deal Technology SAS.
Mr. Henneman received his undergraduate degree from Princeton University in 1983 and his graduate degree from The University of Michigan Law School in 1986.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
R1 RCM INC
0.02% | 08-08-2023 | 72 114 ( 0.02% ) | 928 828 $ | 31-03-2024 |
ANIKA THERAPEUTICS, INC.
0.20% | 14-06-2023 | 29 936 ( 0.20% ) | 760 374 $ | 31-03-2024 |
ORTHOFIX MEDICAL, INC.
0.09% | 12-04-2023 | 34 408 ( 0.09% ) | 499 604 $ | 31-03-2024 |
APREA THERAPEUTICS, INC.
0.15% | 13-03-2024 | 8 139 ( 0.15% ) | 54 450 $ | 31-03-2024 |
Actieve functies van John Henneman
| Bedrijven | Functie | Begin |
|---|---|---|
| R1 RCM INC. | Director/Board Member | 16-02-2016 |
| APREA THERAPEUTICS, INC. | Director/Board Member | 01-08-2019 |
| ANIKA THERAPEUTICS, INC. | Chairman | 24-02-2024 |
| ORTHOFIX MEDICAL INC. | Director/Board Member | 05-01-2023 |
Alafair Biosciences, Inc.
 Alafair Biosciences, Inc. Medical SpecialtiesHealth Technology Alafair Biosciences, Inc. operates as a medical device company. It develops novel suite of products based on a non-cell adhesive hydrogel technology that protects and manages advanced wound healing. The firm addresses problems of wound healing and scar prevention with natural, animal-free biopolymer based products that are biocompatible, bioresorbable and hydrate injured tissues throughout healing. The company was founded by Daniel L. Peterson, John D. Joyoprayitno and Sarah Mayes in 2011 and is headquartered in Austin, TX. | Director/Board Member | 01-01-2015 |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Director/Board Member | 01-08-2019 |
Eerdere bekende functies van John Henneman
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAE HLDG | Director/Board Member | 05-01-2023 |
| LUMOS PHARMA, INC. | Director of Finance/CFO | 26-07-2018 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Director of Finance/CFO | 01-09-2014 |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░ ░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ | - |
Opleiding van John Henneman
| Princeton University | Undergraduate Degree |
| The University of Michigan Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| ANIKA THERAPEUTICS, INC. | Health Technology |
| ORTHOFIX MEDICAL INC. | Health Technology |
| R1 RCM INC. | Commercial Services |
| APREA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
| Neuromedical Systems, Inc. | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Alafair Biosciences, Inc.
Alafair Biosciences, Inc. Medical SpecialtiesHealth Technology Alafair Biosciences, Inc. operates as a medical device company. It develops novel suite of products based on a non-cell adhesive hydrogel technology that protects and manages advanced wound healing. The firm addresses problems of wound healing and scar prevention with natural, animal-free biopolymer based products that are biocompatible, bioresorbable and hydrate injured tissues throughout healing. The company was founded by Daniel L. Peterson, John D. Joyoprayitno and Sarah Mayes in 2011 and is headquartered in Austin, TX. | Health Technology |
SeaSpine Holdings Corp.
 SeaSpine Holdings Corp. Information Technology ServicesTechnology Services SeaSpine Holdings Corp. operates as a medical technology company. The firm engages in the design, developmen and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It products include thoracolumbar hardware, cervical hardware, orthobiologics, and spine pure strip. The company was founded on February 12, 2015 and is headquartered in Carlsbad, CA. | Technology Services |
New Deal Technology SAS
 New Deal Technology SAS Medical SpecialtiesHealth Technology New Deal Technology SAS develops and manufactures specialty implants and instruments for foot and ankle surgery. It offers adjustment guides, ankle prosthesis, fracture plates, compression pins, compression screws, compression staples and flat foot implants. The company was founded in 1997 by Fourcault Eric and is headquartered in Lyon, France. | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
